Nitric oxide modulation of early angiogenesis
β Scribed by J. Scott Isenberg
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 210 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0738-1085
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Angiogenesis is the process of new vessel formation from an existing vasculature network. In all but a few circumstances it is tightly controlled and suppressed. Precise understanding of the factors involved in modulation of angiogenesis has significant potential clinical value. One agent believed to play a role in angiogenesis is nitric oxide. However, there remain substantial uncertainties concerning the specifics of this role. The present study was undertaken to better define the role nitric oxide plays in angiogenesis associated with acute wound healing. Muscle biopsies from the pectoralis major of C57B6 mice were embedded in 500 ΞΌl of type I collagen matrix, and incubated in the presence of growth medium for 14 days. Treatment wells received LβArginine (2 mM), LβNAME (300 ΞΌM), or SNAP (10β20 ΞΌM). Angiogenic response was quantified as the measure of cell migration through the matrix and as the total cells recovered from the matrix. Whole lung specimens and aortic segments served as sources of endothelial and vascular smooth muscle cells respectively for proliferation studies under similar treatment conditions. Nitric oxide was found to exert either a stimulatory or inhibitory effect on angiogenesis and cell proliferation that was subject to the assay system and specific vascular cell types present. These results suggest that the role of nitric oxide in angiogenesis is context dependent. Β© 2004 WileyβLiss, Inc. Microsurgery 24:1β7 2004.
π SIMILAR VOLUMES
nisms with respect to modulation of basal hepatic gly-We perfused livers from fed rats with a balanced salt cogenolysis. In the presence of Ca 2/ , activation of solution containing 1 mmol/L glucose. Under these conphosphorylase with stimulation of glycogenolysis ditions a low steady rate of glycoge
Systemic and especially splanchnic arterial vasodilation accompany chronic portal hypertension. Different soluble mediators causing this vasodilation have been proposed, the strongest evidence being for nitric oxide (NO). No data exist if structural vascular changes may partly account for this vasod